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2780Objectives: Multiple techniques have been used to repair degenerative mitral valve prolapse with leaflet elon-
gation, without creating systolic anterior motion. We describe a simple, reproducible, measured technique to
guide repair.
Methods: From January 2010 to July 2012, 171 patients underwent mitral valve repair; 128 (75%) with Car-
pentier type II prolapse. For 48 patients (37.5%), the resected posterior leaflet free edge was partially folded
to restore the normal 2:1 ratio of the A2 and P2. All patients underwent complete ring annuloplasty sized to
the height of A2.
Results: The preoperative A2/P2 ratio was 1.5 0.5. After repair, the A2/P2 ratio was 1.9 0.3 and 2.0 0.3 in
the no fold and partial fold groups, respectively (P ¼ .57). The ring sizes were larger in the partial fold group
(P<.001) because the A2 height was larger (P¼ .001). No obstructive systolic anterior motion was present. Of
the 171 patients, 91.4% had grade 4þ preoperative mitral regurgitation, with no 3 or 4þ mitral regurgitation
during follow-up. At the last follow-up visit, grade 2þ mitral regurgitation was observed in 5% of the patients.
No 30-day mortalities or reoperations occurred.
Conclusions: Partial fold of the posterior leaflet free edge is a simple technique to restore the normal 2:1 ratio of
A2/P2 with a ring size determined by the A2 height. Using just the A2 height, mitral surgeons can reproducibly
repair the posterior leaflet prolapse, choose the appropriate ring size, and avoid more complex leaflet reconstruc-
tion or judgment of the neochord length. (J Thorac Cardiovasc Surg 2014;148:2780-6)Degenerative mitral valve (MV) disease, especially
Barlow disease, is characterized, not only by chord
elongation and/or rupture leading to prolapse, but also by
elongation of the leaflets with increased height (‘‘tall leaf-
lets’’).1-3 This excess tissue can complicate MV repair for
type II disease, because it can contribute to asymmetric
closure at the point of coaptation and could be a
contributing cause of systolic anterior motion (SAM).2,4
The elongated posterior leaflet can be managed by
resection and reconstruction (sliding-plasty) or, more
recently described, by completely folding the posterior
leaflet over.5-7 However, these techniques have been used
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The Journal of Thoracic and Cardiovascular Surexperience and judgment of the surgeon, which varies
widely.8-10 No general agreement has been reached, even
among the most experienced surgeons, regarding when
the leaflet is ‘‘too tall’’ and needs intervention or what
the height should be after sliding-plasty or foldoplasty;
thus, most surgeons are confused about when these
techniques should be used. Also, no consensus has been
reached regarding the ring types (complete or incomplete,
rigid or flexible) and sizing.11 The repair rates have been
low in low-volume centers and in the hands of surgeons
with little valve experience, likely owing to the complexity
of the pathologic features in type II disease.8,9,11
To gain more precise information about the leaflet
height and variability, we began to directly measure the
leaflet segments before, during, and after repair.3 We
then developed a new precise approach to reconstruct
the posterior leaflet and reestablish the normal ratio of
2:1 between the anterior leaflet height (A2) and posterior
leaflet height (reconstructed P2). We always used a com-
plete ring in the present study, and the ring size was cho-
sen according to the height of A2. We advocate this
technique in patients with type II disease with a ratio
of anterior leaflet height to posterior leaflet height of
>2:1. The objective of the present report was to describe
the findings and measurements, the technique of posterior
leaflet adjustment using partial foldoplasty (PF), and our
early outcomes.gery c December 2014
Abbreviations and Acronyms
LA ¼ left atrial
LV ¼ left ventricular
NF ¼ no fold
PF ¼ partial foldoplasty
SAM ¼ systolic anterior motion
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The data for our project was obtained from the Cardiovascular Research
Database in the Clinical Trial Unit of the Bluhm Cardiovascular Institute at
Northwestern Memorial Hospital. The institutional review board at North-
western University approved the database (project no. STU00012288). The
subjects refusing participation in the project were not included in the pre-
sent analysis.
From January 2010 to July 2012, 128 patients who had undergone MV
repair by 1 surgeon and had had Carpentier type II prolapse were included
in the present study. We compared 2 groups according to the surgical tech-
nique used: (1) PF (n ¼ 48; 37.5%) and (2) no fold (NF; n ¼ 80; 62.5%).
The patient characteristics and associated surgical procedures are summa-
rized in Table 1. The MV leaflet measurements were made directly by the
surgeon using a custom calipers (Table 2), as previously described.3 After
the free edgewas resected and adjusted to the desired level, it wasmeasured
again. The measurements were recorded and entered in custom fields in the
Cardiovascular Research Database. No sliding-plasties and no artificial
chords were used.
Themitral regurgitation (MR) degreewas classified as follows: 0 (none or
trivial), 1þ (mild), 2þ (moderate), 3þ (moderate-to-severe), or 4þ (severe).
Intraoperative transesophageal echocardiography was used in all operations,
and a predischarge echocardiogramwas obtained for all patients. All patients
were prospectively followed up by a dedicated valve nurse. TheMR informa-
tion is listed in Table 3. The follow-up data were 100% complete, and post-
discharge echocardiograms were obtained for 80% of patients at 0.8  0.6
year after surgery. The maximum follow-up period was 2.7 years.TABLE 1. Patient characteristics stratified by group
Characteristic Overall (n ¼ 128)
Age (y) 60.2  12.5
Female sex 49 (38)
NYHA functional class I or II 115 (92)
LVEF (%) 62.0 (58.0, 65.0)
Mitral valve leaflet
Posterior only 100 (84)
Bileaflet 14 (12)
Anterior only 5 (4)
Chordal/leaflet transfer 18 (14)
Edge to edge repair (Alfieri) 10 (8)
Median ring size 32 (32.0, 36.0)
Tricuspid valve surgery 6 (5)
Atrial fibrillation ablation surgery 25 (20)
Coronary artery bypass 15 (12)
Aortic valve surgery 2 (2)
Crossclamp time (min) 67.0 (58.5, 74.5)
Perfusion time (min) 76.0 (68.5, 92.5)
30-d/in-hospital mortality 0 (0)
All-cause long-term mortality 1 (1)
Data presented as mean  standard deviation, n (%), or median (quartile 1, quartile 3). N
ventricular ejection fraction.
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The procedure in the NF group consisted of resection of the prolapsed
segment in 81%. In this group, the remaining posterior leaflet was approx-
imately one half the height of A2 and therefore did not need the PF tech-
nique, and the edges of the resection were closed in 2 layers. The
reconstructed segment was measured and termed the ‘‘reconstructed poste-
rior leaflet height,’’ and a ring size (median, 32 mm) was chosen according
to the A2 height (24.9  3.5 mm).
Technique of Posterior Leaflet Height Adjustment
Using PF
A trapezoid resection of the flail or prolapsing segment (Figure 1, A)
was performed, preserving the normal length chords on either side of the
resection (Figure 1, B). The posterior annulus was plicated. The desired
height of the posterior leaflet was one half the height of A2. A 5-0 Ethibond
(Ethicon, Somerville, NJ) suture was placed from the left atrial (LA) to left
ventricular (LV) aspect of the medial leaflet, typically 4 to 5 mm less than
the desired height, from the LV to LA side of the leaflet at the chord
attached to the free edge, thereby partially folding the free edge
(Figure 1, C). The suture was then taken from the LA to LV side of the
free edge of the lateral leaflet and back from the LV to LA side below
the desired height (Figure 1, C). Tension on the suture causes both sides
to fold over, creating a new free edge at the desired height (Figure 1, D).
A second suture is placed at the free edge, through adjacent chordae, and
both sutures are sewn down to the annulus and tied, taking care to smooth
out raised areas of leaflet tissue (Figure 2, A and B). If indentations remain
between the P1 and P2 remnant and the P2 and P3 remnant, they are
routinely closed (Figure 2,C andD), and the completed repair is symmetric
and properly proportioned to the height of A2. A complete remodeling ring
is chosen according to the height of A2 (Figure 3). In some cases, only 1
side of the resection will be elongated. This is easily managed by PF of
the side that is too long and passing the suture from the ventricular to atrial
side of the opposing leaflet segment that is already at the desired height.
Chord transfer was used in 9 (13%) of the NF and 8 (17%) of PF patients,
with an edge-to-edge approximation in 7 (9%) of the NF and 3 (6%) of the
PF patients. Of these, procedures, 7 were central (5 in the NF and 2 in theNF group (n ¼ 80) PF (n ¼ 48) P value
62.1  13.7 56.9  9.5 .022
30 (38) 19 (40) .81
72 (91) 43 (93) .64
61.0 (60.0, 65.0) 62.0 (55.0, 65.0) .83
.93
59 (83) 41 (85)
9 (13) 5 (10)
3 (4) 2 (4)
10 (13) 8 (17) .48
7 (9) 3 (6) .61
32.0 (30.0, 34.0) 34.0 (32.0, 37.0) <.001
4 (5) 2 (4) .83
15 (19) 10 (21) .77
12 (15) 3 (6) .14
1 (1) 1 (2) .68
67.0 (58.5, 75.0) 67.5 (59.0, 74.5) .78
75.5 (68.0, 94.0) 77.0 (70.0, 88.0) .99
0 (0) 0 (0)
0 (0) 2 (4) .07
F, No fold; PF, partial foldoplasty; NYHA, New York Heart Association; LVEF, left
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TABLE 2. Summary of patient operative measurements
Variable
Overall (n ¼ 128) NF (n ¼ 80) PF (n ¼ 48)
P valueAvailable (n) Mean ± SD Available (n) Mean ± SD Available (n) Mean ± SD
Commissure to commissure (mm) 122 45.4  6.0 75 45.4  5.4 47 45.4  6.8 .98
P1 height (mm) 123 11.0  3.1 75 10.1  2.2 48 12.5  3.7 <.001
P2 height (mm) 125 19.0  5.3 78 17.0  4.9 47 22.3  4.0 <.001
P3 height (mm) 125 13.0  3.6 77 12.2  3.4 48 14.2  3.8 .002
A2 height (mm) 127 25.8  3.9 79 24.9  3.5 48 27.2  4.1 .001
P2 after reconstruction 83 13.6  1.9 41 13.1  1.7 42 14.0  2.0 .023
A2/P2 ratio before reconstruction 125 1.5  0.5 78 1.6  0.6 47 1.2  0.2 <.001
A2/P2 ratio after reconstruction 83 1.9  0.3 41 1.9  0.3 42 2.0  0.3 .57
Coaptation P1 (mm) 85 5.6  1.5 47 5.4  1.6 38 5.9  1.2 .12
Coaptation P2 (mm) 84 6.3  1.5 46 6.3  1.5 38 6.3  1.4 .85
Coaptation P3 (mm) 84 5.5  1.4 46 5.3  1.5 38 5.6  1.3 .30
Coaptation A1 (mm) 85 5.2  1.3 47 5.0  1.4 38 5.5  1.2 .08
Coaptation A2 (mm) 84 5.4  1.4 46 5.0  1.2 38 5.8  1.5 .012
Coaptation A3 (mm) 84 4.8  1.3 46 4.5  1.2 38 5.1  1.3 .043
NF, No fold; SD, standard deviation; PF, partial foldoplasty.
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commissuroplasties.
Statistical Analysis
Continuous data were summarized using either the mean standard de-
viation or median and first and third quartiles. For discrete variables, theTABLE 3. Summary of echocardiography-based MR and MV gradients
Variable Overall (n ¼ 128)
Preoperative MR 128
0 0 (0.0)
1þ 0 (0.0)
2þ 8 (6.3)
3þ 0 (0.0)
4þ 120 (93.8)
Off-CPB MR* 99
0 88 (89)
1þ 10 (10)
2þ 1 (1)
3þ 0 (0)
4þ 0 (0)
Predischarge MR* 127
0 115 (90.6)
1þ 8 (6.3)
2þ 4 (3.1)
3þ 0 (0)
4þ 0 (0)
MR at last follow-up visit 103
0 69 (67.0)
1þ 28 (27.2)
2þ 5 (5.8)
3þ 0 (0)
4þ 0 (0)
MV gradient at last follow-up visit (mmHg) —
Data presented as n, n (%), or mean  standard deviation.MR, Mitral regurgitation;MV, m
patient in the NF group had temporary chordal systolic anterior motion off CPB and one in
echocardiographic data available.
2782 The Journal of Thoracic and Cardiovascular Surcounts and percentages are reported. Paired t tests were used to compare
the preoperative and postoperative leaflet measurements within the same
group. Group comparisons of preoperative, off-cardiopulmonary bypass,
predischarge and last follow-up MR degree, and MV implant sizes were
performed using Fisher’s exact test. All statistical analyses were performed
using SAS, version 9.3, statistical software (SAS Institute Inc, Cary, NC).NF (n ¼ 80) PF (n ¼ 48) P value
80 48 .13
0 (0.0) 0 (0.0)
0 (0.0) 0 (0)
3 (3.8) 5 (10.4)
0 (0) 0 (0)
77 (96.3) 43 (89.6)
66 33 .82
59 (89.4) 29 (87.9)
6 (9.1) 4 (12.1)
1 (1.5) 0 (0)
0 (0) 0 (0)
0 (0) 0 (0)
80 47 .39
71 (88.8) 44 (93.6)
7 (8.8) 1 (2.1)
2 (2.5) 2 (4.3)
0 (0) 0 (0)
0 (0) 0 (0)
63 40 .64
40 (63.5) 29 (72.5)
19 (31.2) 9 (22.5)
4 (6.3) 2 (5.0)
0 (0) 0 (0)
0 (0) 0 (0)
3.5  1.4 2.6  1.1 .009
itral valve; NF, no fold; PF, partial foldoplasty; CPB, cardiopulmonary bypass. *One
the PF group had chordal systolic anterior motion at discharge, with no late follow-up
gery c December 2014
FIGURE 1. Valve resection and initial steps of repair. A, The myxomatous valve typically has elongated leaflets with type II disease, most pronounced in
the P2 segments and A2. B,We perform trapezoid resection of the involved segment, preserving the normal length primary chords at the leaflet free edge and
secondary chords in the body of the leaflet. The remaining tissue height will vary but could still be more than one half the height of A2. Inset, A single
nonpledgeted annular plication suture is placed. C, The desired height of the posterior leaflet is one half of the A2 (28 mm in this example) and, therefore,
ideally, would be 14mm. Inset, A single-arm 5-0 braided suture is placed to partially fold the leaflet to the desired height. For example, if the remaining tissue
were 18 mm, the stitch would be placed 4 mm below the desired point (14 mm) from the atrial to ventricular side of the leaflet toward P3. The stitch would
then pass from the ventricular to atrial side at the free edge (18mm) at the normal length primary chord. The stitch is then passed from the atrial to ventricular
side at the free edge (toward P1) and exits from the ventricular side back to the atrial side at a distance to reduce the folded height to 14 mm. D, When the
suture is pulled taut, the free edge will partially fold down, and the ‘‘new’’ free edge will be 14 mm above the annulus.
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justments for multiplicity.RESULTS
The PF group was significantly younger than the NF
group (age, 56.9  9.5 vs 62.1  13.74 years; P ¼ .022)
and had less congestive heart failure (10% vs 28%;
P ¼ .022). In keeping with the current guidelines for early
referral, most patients (92%) were New York Heart Associ-
ation functional class I or II (P ¼ .64 between groups). The
beginning A2 and P2 heights were elongated, as expected
with this pathologic condition (Table 1), especially in those
who underwent PF. It has been suggested that youngerThe Journal of Thoracic and Carpatients more often have Barlow disease and, therefore,
longer leaflets.12
Before reconstruction, the A2/P2 ratio was abnormal in
both the NF group (1.6  0.6) and the PF group (1.2 
0.2; P< .001). In addition, the P2 and A2 leaflets were
both taller in the PF than in the NF group (22.3  4.0 mm
vs 17.0  4.9 mm, P<.001; and 27.2  4.1 mm vs 24.9
 3.5 mm, P ¼ .001, respectively). The commissure to
commissure distance was similar in the PF and NF groups
(45.4  6.8 mm vs 45.4  5.4 mm, P ¼ .98), confirming
a dilated annulus in both groups, as expected.
After reconstruction, both groups had been restored to
the normal A2/P2 ratio (NF group, 1.9  0.3 vs PF group,diovascular Surgery c Volume 148, Number 6 2783
FIGURE 2. Completion of posterior leaflet repair. A,We use a double suture line to close the posterior leaflet for strength and to ensure no gaps are present.
This also ensures that the surface of coaptation is as smooth as possible. The second stitch is placed at the free edge, including the adjacent free edge chords,
such that the reconstructed free edge is supported. B, Both sutures are tied, and a continuous running suture ends at the annulus. The reconstructed leaflet will
be 14 mm and one half the A2. C, The indentations separating P1 from P2 and P2 from P3 contain normal length chords but can become more open after
resection and reconstruction of the P2. These are closed with a figure-of-8, 5-0 braided suture, which also supports the new free edge of the reconstructed
segment with the adjacent normal chordae. D, The reconstructed leaflet is a symmetric uniform height and properly proportioned to the anterior leaflet.
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group, the reconstructed P2was slightly taller in the PFgroup
than in the NF group (14  2 mm vs 13.1  1.7 mm;
P ¼ .023). None of the patients had a reconstructed P2 that
was>3 mm different than the desired height, indicating
that the technique was quite accurate. Because the A2 was
taller in the PF group, these patients generally received larger
rings: 37.5% were size 36, 38, or 40 in the PF group
compared with 20% in the NF group (Figure 3). After repair,
the ventricle was distended with saline, and the ‘‘ink test’’
was used to mark the coaptation line. The portion of the
leaflet that overlaps was then measured using the calipers
and recorded. The ‘‘target’’ 5-mm coaptation of the leaflets
was achieved, was generally symmetric across all segments
of both leaflets in both groups. It ranged from 4.58  1.2
mm to 6.3  1.5 mm (Table 2). In the PF group, more
coaptation was seen at the anterior leaflet segments,
A2 (5.8  1.5 mm vs 5.0  1.2 mm; P ¼ .012) and A3
(5.1  1.3 mm vs 4.5  1.2 mm; P ¼ .043) but not A12784 The Journal of Thoracic and Cardiovascular Sur(5.5  1.2 mm vs 5.0  1.4 mm; P ¼ .08). No differences
were found in the coaptation of the posterior leaflet segments.
The echocardiographic findings were consistent in both
groups (Table 3). In the overall cohort, severe (4þ) MR
was present in 93.8% before surgery. Off bypass
(n ¼ 99), no grade 3þ or 4þ MR was present, and only 1
NF patient (1.5%) had grade 2þ MR. No case of obstruc-
tive SAM and 1 case of temporary ‘‘chordal’’ SAM
occurred.
Before discharge (n ¼ 127), no patient had grade 3þ or
4þ MR, 4 patients (3.1%) had grade 2þ MR (2 NF
[2.5%] and 2 PF [4.3%]) and 8 patients (6.3%) had grade
1þMR (7 NF [8.8%] and 1 PF [2.1%]). At the last follow-
up visit (n ¼ 103), no patient had grade 3þ or 4þ MR, 6
(5.8%) had grade 2þ MR (4 NF [6.3%] and 2 PF
[5.0%]), and 28 patients (27.3%) had grade 1þ MR (9
PF [22.5%] and 19 NF [30.2%]). No statistically signifi-
cant differences were found in MR grade between the PF
and NF groups at any point.gery c December 2014
FIGURE 3. The distribution of ring sizes shown for those patients with partial foldoplasty and those with no fold.
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both groups, but the differences were statistically significant
in the NF group compared with the PF group (3.5 1.4 mm
Hg vs 2.6  1.0 mm Hg, P ¼ .009).
After discharge, 1 patient died of sudden death at 5 weeks
and 1 died of sepsis and suspected endocarditis at a different
institution almost 2 years after repair. Both patients were in
the PF group.
DISCUSSION
PF is an easy, reliable, and reproducible technique to
restore the normal 2:1 relationship between the A2 and P2
height. The nonresected chords are sewn together at the
free edge and further supported by closing the indentations
between P1-P2 and P2-P3. With the normal relationship of
the A2/P2 height restored, the surgeon simply chooses the
appropriate size ring to avoid SAM. This eliminates or min-
imizes the need for sliding-plasty. Intraoperatively, our
echocardiographers routinely measured the distance be-
tween the posterior leaflet coaptation point to the septum
and other factors, such as the mitral–aortic angle, both of
which can contribute to SAM. However, the surgeon deter-
mines the ring size and posterior leaflet height; thus, those
factors were under our control.
The techniques for repairing degenerative mitral disease
include sliding-plasty, complete nonmeasured FP, posterior
leaflet plication, edge-to-edge repair, chordal replacement,
and annuloplasty ring placement.2,5-7,13-16 Folding, sliding,The Journal of Thoracic and Carand plicating attempt to treat the underlying pathologic
features by shortening the posterior leaflet. Sliding involves
resection of the leaflet tissue and plication of the posterior
mitral annulus and requires multiple suture lines. Folding
and plicating reduce the removal of leaflet tissue and might
eliminate the need for annular plication; however, they
are not measured and require surgeon judgment. With
plication, the recommendation remains to insert artificial
chordae, necessitating proper length determination.7,17 Our
technique differs from ‘‘foldoplasty’’ or folding plasty
for those reasons and is targeted to create a 2:1 ratio.
Neochordal reconstruction without leaflet resection does
not address the elongation seen with degenerative disease
and is better used to correct isolated prolapse.15 All these re-
pairs include placement of an annuloplasty ring.2,5-7,13-15
Although the edge-to-edge repair can be used in isolation
to correct degenerative MV disease, it is rarely performed
without annuloplasty owing to the suboptimal late results
without annuloplasty.14 With myxomatous disease, place-
ment of an annuloplasty ring alone has been discouraged,
because the use of a downsized ring could predispose the pa-
tient to SAM and even placement of a large ring can require
complex posterior leaflet reconstruction.2
Bolling and colleagues9 demonstrated that MV repair is
underused (41% repair rate for all mitral operations). A pre-
vious report8 indicated most repairs are just rings, indi-
cating that resection and reconstruction add a layer of
complexity that is difficult to overcome when the averagediovascular Surgery c Volume 148, Number 6 2785
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believe this difficulty can be overcome through education
and institution of reproducible techniques that are not
dependent on the art and experience of MV surgeons, but
on a precisely measured technique with a clear goal for
reconstruction and an approach for proper ring sizing to
avoid SAM.
Study Limitations
Although ours was not a randomized trial, the data were
gathered prospectively in our database. As a referral center,
not all patients returned for the follow-up echocardiogram,
although the clinical follow-up data were 100%. The tech-
nique we believe is best reproduced uses measurements that
have not been routine inMV surgery, includingmeasurement
of theA2 length and theheight of the posterior scallops. These
measurements need to be taught but are straightforward.
Once routine, we believe that these quantitative data will
not be a limitation, because they only add 1 minute and func-
tion objectively to guide reconstruction and ring sizing.CONCLUSIONS
PF is a simple, reproducible technique to restore the normal
leaflet height ratios.When combinedwith themeasured ante-
rior leaflet height to determine the ring size, the results have
been favorable in early follow-up. This approach can result
in reliable repair for less experienced users.References
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